HistoSonics, GE Healthcare agree to integrate ultrasound into sonic beam liver therapy

[Image from HistoSonics]HistoSonics announced today that it agreed with GE Healthcare to use its ultrasound imaging to power novel sonic beam therapy.

Minneapolis-based HistoSonics’ agreement formalizes ongoing efforts to use GE Healthcare’s Logiq E10 Series ultrasound imaging platform to power the real-time visualization features of HistoSonics’ sonic beam liver therapy platform.

Under the agreement — and upon market authorization — HistoSonics will distribute GE Healthcare’s Logiq E10 Series in a one-to-one basis with its breakthrough liver therapy system, according to a news release.

HistoSonics designed its Edison system to use histotripsy to non-invasively destroy targeted liver tissue. Edison mechanically destroys and liquified targeted tissues at a sub-cellular level. The company said it plans to use GE Healthcare’s imaging platform to offer continuous visualization for key and unique elements of the histotripsy therapy …

Read more
  • 0

HistoSonics announces $40m Series C

Non-invasive robotics platform and sonic beam therapy developer HistoSonics announced today that it closed a Series C-1 financing worth $40 million.

Yonjin Venture led the oversubscribed funding round, while Varian Medical Systems, Johnson & Johnson Innovation, Venture Investors, Lumira Ventures, State of Wisconsin Investment Board and more participated as well, according to a news release.

Minneapolis-based HistoSonics intends to use the proceeds to accelerate activities centered around its Edison platform for non-invasive, personalized treatments with histotripsy for destroying targeted tissues at sub-cellular levels. Other funds may be used to launch new strategic projects as well.

Through histotripsy and focused sound energy, the Edison platform generates pressures strong enough to liquify and destroy those targeted tissues, offering the ability of the treatment site to recover and heal quickly while giving physicians a chance to monitor the dest…

Read more
  • 0